Literature DB >> 3713940

Peritonitis in continuous ambulatory peritoneal dialysis: analysis of an 8-year experience.

B Prowant, K Nolph, L Ryan, Z Twardowski, R Khanna.   

Abstract

Experiences with peritonitis in a continuous ambulatory peritoneal dialysis (CAPD) program at a single center over 8 years were reviewed. Home-acquired peritonitis rates have been less than 1 episode per patient year since 1982. Gram-positive organisms continue to account for most episodes in a similar proportion. Actual known contamination could be pinpointed in only 7.4% of cases, but was strongly suspected in 35.8% of episodes. Exit site and/or tunnel infections were thought to have caused 20% of the cases. Intrinsic peritonitis probably accounted for 10.5%. Recurrence of peritonitis with the same organisms following cessation of antibiotics represented only 2.1% of cases.

Entities:  

Mesh:

Year:  1986        PMID: 3713940     DOI: 10.1159/000183807

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  8 in total

1.  Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis.

Authors:  J L Schmit; L Hary; P Bou; H Renaud; P F Westeel; M Andrejak; A Fournier
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

2.  Paecilomyces variotii in peritoneal dialysate.

Authors:  A Marzec; L G Heron; R C Pritchard; R H Butcher; H R Powell; A P Disney; F A Tosolini
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

3.  Pharmacokinetics of imipenem-cilastatin in patients with renal insufficiency undergoing continuous ambulatory peritoneal dialysis.

Authors:  P Somani; E H Freimer; M L Gross; J T Higgins
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

4.  Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases.

Authors:  Cheuk-Chun Szeto; Bonnie Ching-Ha Kwan; Kai-Ming Chow; Miu-Fong Lau; Man-Ching Law; Kwok-Yi Chung; Chi-Bon Leung; Philip Kam-Tao Li
Journal:  Clin J Am Soc Nephrol       Date:  2007-11-21       Impact factor: 8.237

5.  Acinetobacter peritoneal dialysis peritonitis: a changing landscape over time.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Wei-Shun Yang; Huei-Wen Chen; Cheng-Chung Fang; Chung-Jen Yen; Chih-Kang Chiang; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  PLoS One       Date:  2014-10-14       Impact factor: 3.240

6.  Peritonitis from facultative anaerobic gram-negative bacilli likely due to translocation of bacteria from gut in a patient undergoing peritoneal dialysis.

Authors:  Sreedhar Adapa; Srikanth Naramala; Harmandeep Singh Tiwana; Niraj Patel; Raman Verma; Narayana Murty Koduri; Venu Madhav Konala
Journal:  Infect Dis Rep       Date:  2020-04-16

7.  Citrobacter peritoneal dialysis peritonitis: rare occurrence with poor outcomes.

Authors:  Chia-Ter Chao; Szu-Ying Lee; Wei-Shun Yang; Huei-Wen Chen; Cheng-Chung Fang; Chung-Jen Yen; Chih-Kang Chiang; Kuan-Yu Hung; Jenq-Wen Huang
Journal:  Int J Med Sci       Date:  2013-07-04       Impact factor: 3.738

8.  Hyponatremia is a surrogate marker of poor outcome in peritoneal dialysis-related peritonitis.

Authors:  Min-Hua Tseng; Chih-Jen Cheng; Chih-Chien Sung; Yu-Ching Chou; Pauling Chu; Giien Shuen Chen; Shih-Hua Lin
Journal:  BMC Nephrol       Date:  2014-07-10       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.